The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

US health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk t… ...

Popular heartburn drug Ranitidine, long under scrutiny, will continue to be available in India as the government confirmed it had no plans to ban its manufacture or sale. The government had ...

Versions of the drug have been found to contain low levels of a carcinogen. But it’s still on pharmacy shelves. Here’s what you need to know. By Katie Thomas This article was updated on Sept ...

79,000. That’s how many cases related to Zantac GSK still face, according to Reuters. The majority of these, some 73,000, are in Delaware, ...

That said, this bulletin is not a notice of yet another impending recall, as the FDA notes that it’s still determining how big of a risk this particular discovery poses to the public.

Lab investigates heartburn drug’s possible cancer link 04:53. Washington — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after ...

Ideally Ranitidine can produce other side effects as well in some people like diarrhea, headache, nausea, indigestion, abdominal pain, auto immune hemolytic anemia.

Safe alternatives to Zantac are available. The drug is one of several H2-receptor antagonists (H2RAs), including cimetidine (Tagamet) and famotidine (Pepcid).

Novartis is halting distribution of the popular heartburn drug Zantac due to low levels of cancer-causing contaminant. Medication already in stores will still be available as FDA reviews safety of ...